|drug3363||Test PCR Wiki||1.00|
|drug780||Clinical Examination Wiki||0.71|
|D002547||Cerebral Palsy NIH||0.71|
|D002658||Developmental Disabilities NIH||0.71|
There is one clinical trial.
Covid-19 In Tunisia: AN Observational Cross-Sectional Registry Study
Description: Identify differences related to epidemiological demographic characteristics and the profile of COVID(+) vs. the profile of COVID(-) patients who have been in contact with COVID(+) Vaccination History Questionnaire Medical and Surgical History Questionnaire Clinical Examination TDR and blood sampling for DNA ChecksMeasure: Differences related to epidemiological demographic characteristics Time: 30 days
Data processed on January 01, 2021.
An HTML report was created for each of the unique drugs, MeSH, and HPO terms associated with COVID-19 clinical trials. Each report contains a list of either the drug, the MeSH terms, or the HPO terms. All of the terms in a category are displayed on the left-hand side of the report to enable easy navigation, and the reports contain a list of correlated drugs, MeSH, and HPO terms. Further, all reports contain the details of the clinical trials in which the term is referenced. Every clinical trial report shows the mapped HPO and MeSH terms, which are also hyperlinked. Related HPO terms, with their associated genes, protein mutations, and SNPs are also referenced in the report.Drug Reports MeSH Reports HPO Reports